甲状腺3升调与患有异常性炎症性肌肉病变的患者的肌肉参与有关
Huan Liu1, Ying Ren2, Qianwei Li1
1Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Number 37 Guoxue Alley in the Wuhou District, Chengdu, 610041, China.
Immunologic research
|September 16, 2025
概括
可溶性Tyro3 (sTyro3) 水平在异常性炎症性肌肉病 (IIM) 中升高,表明Tyro3的存在.
科学领域:
- 免疫学和自身免疫性疾病
- 分子生物学和生物标志物
背景情况:
- 甲状腺3,轴和Mer (TAM) 受体在免疫和自身免疫性疾病的进展中发挥作用.
- 异形性炎症性肌肉病 (IIM) 是一种影响肌肉的自身免疫性疾病.
研究的目的:
- 研究TAM受体,特别是Tyro3在IIM患者中的作用.
- 评估IIM肌肉组织中的可溶性TAM (sTAM) 水平和Tyro3表达.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 用于测量血清中可溶性TAM (sTAM) 水平.
- 西方斑块和免疫组织化学 (IHC) 分析肌肉组织中的Tyro3蛋白表达.
- 从176名IIM患者和50名健康对照 (HC) 的临床数据分析.
主要成果:
- 在IIM患者中,与HC患者相比,观察到高的sTAM水平,特别是可溶性Tyro3 (sTyro3).
- 在皮肤肌炎 (DM) 和免疫媒介性死肌病 (IMNM) 患者中发现了较高的sTyro3度.
- 在IMNM和DM患者的死亡肌肉中,Tyro3表达显著.
结论:
- 泰罗3有助于IIM的肌肉损伤,这表明它是一个潜在的生物标志物.
- 在IMNM和DM患者治疗后降低的sTyro3水平表明了治疗潜力.
- 泰罗3被确定为异常性炎症性肌肉病的潜在治疗标.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Myocarditis II: Clinical Features and Diagnostic Tests
267
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
267
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175


